Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-10-02 | SpringWorks Therapeutics, Inc. | Lin Tai-An
(Chief Scientific Officer) |
F | Common Stock | D | 2324 | $32.83 - $32.83 | $76,296 |
2024-06-03 | SpringWorks Therapeutics, Inc. | Islam Saqib
(Chief Executive Officer) |
S | Common Stock | D | 49000 | $39.40 - $42.09 | $1,955,111 |
2024-06-03 | SpringWorks Therapeutics, Inc. | Hambleton Julie
(Director) |
S | Common Stock | D | 4648 | $39.41 - $42.09 | $186,046 |
2024-06-03 | SpringWorks Therapeutics, Inc. | Edris Badreddin
(Chief Operating Officer) |
S | Common Stock | D | 20000 | $39.40 - $42.04 | $801,371 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |